23-O-beta-D-Glucopyranosyl-25-methyldolichosterone



Compound IDCDAMM01524
Common name23-O-beta-D-Glucopyranosyl-25-methyldolichosterone
IUPAC name2,3-dihydroxy-17-[3-hydroxy-6,6-dimethyl-5-methylidene-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-yl]-10,13-dimethyl-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-6-one
Molecular formulaC35H58O10

Experimental data

Retention time10.83
Adduct[M+H]+
Actual mz639.419
Theoretical mz639.41
Error13.49
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.95

Identifiers and class information

Inchi keyNLNNWFCVCWSYSK-KZSJBWCONA-N
SmilesO=C1CC2C3CCC(C(C)C(O)C(OC4OC(CO)C(O)C(O)C4O)C(=C)C(C)(C)C)C3(C)CCC2C5(C)CC(O)C(O)CC15
SuperclassLipids and lipid-like molecules
ClassSteroids and steroid derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)5
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)15
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)638.837
Computed dipole moment(dipole)9.07
Total solvent accessible surface area (SASA)915.385
Hydrophobic component of SASA (FOSA)589.624
Hydrophilic component of SASA (FISA)315.754
Pie component of the SASA (PISA)10.008
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1886.7
Number of hydrogen bond donors (donorHB)7
Number of hydrogen bond acceptors (accptHB)17.3
Free energy of solvation of dipole (dip^2/V)0.0436022
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0500024
Globularity descriptor (glob)0.806671
Predicted polarizability in cubic angstroms (QPpolrz)59.816
Predicted hexadecane/gas partition coefficient (QPlogPC16)19.322
Predicted octanol/gas partition coefficient (QPlogPoct)40.653
Predicted water/gas partition coefficient (QPlogPw)28.122
Predicted octanol/water partition coefficient (QPlogPo/w)1.124
Predicted aqueous solubility (QPlogS)-4.251
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.949
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.708
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)10.037
Predicted brain/blood partition coefficient (QPlogBB)-3.576
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)3.422
Predicted skin permeability, log Kp (QPlogKp)-5.863
PM3 calculated ionization potential (IP(ev))10.294
PM3 calculated electron affinity (EA(eV))-0.583
Number of likely metabolic reactions (#metab)10
Prediction of binding to human serum albumin (QPlogKhsa)-0.294
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)25.537
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)187.51
Number of nitrogen and oxygen atoms (#NandO)10
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q9UHC9NPC1L1Niemann-Pick C1-like protein 1T33901SEA
Q8TDU6GPBAR1G-protein coupled bile acid receptor 1T86273SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P60568IL2Interleukin-2T61698SEA
P14679TYRTyrosinaseT97035SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T33901DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]Q9UHC9NPC1L1
T86273DI0417Type 2 diabetes mellitus[ICD-11: 5A11]Q8TDU6GPBAR1
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR

Copyright © 2025